A lytic phage targeting virulent Proteus mirabilis for effective biofilm eradication
Microbial Pathogenesis · 2026-06 · 215 · 108469
DOI: 10.1016/j.micpath.2026.108469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026-06. Verfasst von Wenjie Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, China. Hauptthemen laut MEDLINE: Biofilms, Proteus mirabilis, Bacteriophages, Phage Therapy. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Yangzhou University, Graduate Research and Innovation Projects of Jiangsu Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Proteus mirabilis is an opportunistic pathogen frequently associated with catheter-associated urinary tract infections (CAUTIs), where robust crystalline biofilms contribute to chronicity, antimicrobial tolerance, and recurrence. The rising prevalence of multidrug-resistant (MDR) P. mirabilis has prompted interest in bacteriophage therapy as an alternative to conventional antibiotics. In this study, we isolated a lytic bacteriophage, vB_PmiM_ZX7, from sewage using a highly virulent clinical strain, P. mirabilis YV2, as the host. vB_PmiM_ZX7 displayed a broad host range among MDR P. mirabilis isolates and tolerance to a wide range of pH and temperatures. Genome sequencing revealed 60% of genes with unknown function, absence of virulence or antibiotic resistance genes, and limited similarity to known P. mirabilis phages, underscoring its genomic novelty. Safety evaluation in a murine model showed no adverse effect, histopathological changes, or persistent phage accumulation. Circulating phages were cleared from the blood within 5 h and from organs within 48 h. In anti-biofilm assays, vB_PmiM_ZX7 eradicated 62.2% of established biofilms, outperforming piperacillin/tazobactam (TZP), and significantly reduced extracellular polysaccharide content and biofilm density, as confirmed by scanning electron microscopy and fluorescence imaging. Furthermore, vB_PmiM_ZX7 demonstrated strong anti-biofilm activity in an in vitro catheter-associated biofilm model, markedly reducing the viability of biofilm-associated bacteria in a time-dependent manner. These findings demonstrated the potential of vB_PmiM_ZX7 as a therapeutic candidate for catheter-associated MDR P. mirabilis infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, China.
- Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
- College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, China; Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China. Electroni…
Förderung
- Yangzhou University
- Graduate Research and Innovation Projects of Jiangsu Province
- National Key Research and Development Program of China
Zitieren
APA
Ma, W., Li, P., & Zhou, X. (2026). A lytic phage targeting virulent Proteus mirabilis for effective biofilm eradication. Microbial Pathogenesis, 215, 108469. https://doi.org/10.1016/j.micpath.2026.108469
Vancouver
Ma W, Li P, Zhou X. A lytic phage targeting virulent Proteus mirabilis for effective biofilm eradication. Microbial Pathogenesis. 2026;215:108469. doi:10.1016/j.micpath.2026.108469
BibTeX
@article{Ma2026,
author = {Ma, Wenjie and Li, Ping and Zhou, Xin},
title = {A lytic phage targeting virulent Proteus mirabilis for effective biofilm eradication},
journal = {Microbial Pathogenesis},
year = {2026},
volume = {215},
pages = {108469},
doi = {10.1016/j.micpath.2026.108469}
}
EUVIMED